BioInvent International AB

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0015244520
SEK
29.05
1.9 (7.0%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
198.10
22.06
21.37
12.76
4.61
5.94
15.32
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
198.10
22.06
21.37
12.76
4.61
5.94
15.32
Raw Material Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
44.00
35.30
40.40
29.90
38.10
31.60
39.40
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
13.30
12.32
12.82
7.99
9.60
8.59
10.58
Other Expenses
10.07
9.25
8.89
7.76
10.05
5.08
7.22
Total Expenditure (Excl Depreciation)
157.99
140.15
142.12
115.45
148.19
90.97
122.17
Operating Profit (PBDIT) excl Other Income
40.099999999999994
-118.10000000000001
-120.7
-102.69999999999999
-143.6
-85
-106.89999999999999
Other Income
3.86
6.63
8.79
10.31
11.18
11.83
14.46
Operating Profit (PBDIT)
43.97
-111.46
-111.96
-92.38
-132.40
-73.20
-92.39
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
5.07
5.14
4.88
4.83
4.88
4.71
4.56
Profit Before Tax
38.90
-116.59
-116.83
-97.21
-137.28
-77.92
-96.95
Tax
0.10
0.04
0.05
0.03
0.03
0.03
0.20
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
38.80
-116.63
-116.88
-97.24
-137.31
-77.95
-97.16
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
38.80
-116.63
-116.88
-97.24
-137.31
-77.95
-97.16
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
38.80
-116.63
-116.88
-97.24
-137.31
-77.95
-97.16
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.2
0.2
0.2
0.2
0.2
0.2
0.2
Reserves
810.74
769.73
885.82
1,003.09
1,097.52
1,232.64
1,309.73
Earnings per share (EPS)
0.59
-1.77
-1.78
-1.48
-2.09
-1.18
-1.48
Diluted Earnings per share
0.59
-1.77
-1.78
-1.48
-2.09
-1.18
-1.48
Operating Profit Margin (Excl OI)
17.69%
-558.58%
-587.87%
-842.38%
-3219.74%
-1510.33%
-727.29%
Gross Profit Margin
22.2%
-505.25%
-523.92%
-723.77%
-2871.35%
-1231.98%
-603.14%
PAT Margin
19.59%
-528.7%
-546.96%
-761.85%
-2977.81%
-1311.78%
-634.24%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is 796.38% vs 3.27% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is 133.28% vs 0.26% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is 133.95% vs 2.15% in Mar 2025

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

Compare Quarterly Results Of BioInvent International AB With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(SEK)
Change(%)
Net Sales
198.10
324.20
-126.10
-38.90%
Other Operating Income
0.00
0.00
0.00
Total Operating income
198.10
324.20
-126.10
-38.90%
Raw Material Cost
0.00
224.60
-224.60
-100.00%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
44.00
0.00
44.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
77.20
-77.20
-100.00%
Selling and Distribution Expenses
13.30
174.60
-161.30
-92.38%
Other Expenses
10.07
-4.35
14.42
331.49%
Total Expenditure (Excl Depreciation)
157.99
432.90
-274.91
-63.50%
Operating Profit (PBDIT) excl Other Income
40.11
-108.70
148.81
136.90%
Other Income
3.86
8.30
-4.44
-53.49%
Operating Profit (PBDIT)
43.97
-56.30
100.27
178.10%
Interest
0.00
77.20
-77.20
-100.00%
Exceptional Items
0.00
-2.80
2.80
100.00%
Gross Profit (PBDT)
0.00
99.60
-99.60
-100.00%
Depreciation
5.07
44.10
-39.03
-88.50%
Profit Before Tax
38.90
-180.30
219.20
121.58%
Tax
0.10
1.30
-1.20
-92.31%
Provisions and contingencies
0
0
0.00
Profit After Tax
38.80
-179.90
218.70
121.57%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
38.80
-179.90
218.70
121.57%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
-1.80
1.80
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
38.80
-181.70
220.50
121.35%
Equity Capital
0
0
0.00
Face Value
0.20
0.03
0.00
Reserves
810.74
2,445.40
-1,634.66
-66.85%
Earnings per share (EPS)
0.59
-2.61
3.20
122.61%
Diluted Earnings per share
0.59
-2.61
3.20
122.61%
Operating Profit Margin (Excl OI)
17.69%
-33.53%
0.00
51.22%
Gross Profit Margin
22.20%
-42.01%
0.00
64.21%
PAT Margin
19.59%
-55.49%
0.00
75.08%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 19.81 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 796.38% vs 3.27% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 4,206.52% vs -64.89% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 3.88 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 133.28% vs 0.26% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 128.26% vs -55.49% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4.01 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 133.95% vs 2.15% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 127.92% vs -54.08% in Jun 2024

Quarterly - Interest
Markets Mojo
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.69%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024